Nature of the Event
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) regarding the reclassification of promoters due to a change in control of Bliss GVS Pharma Limited.
Key Details
- The disclosure references a previous submission to stock exchanges on September 28, 2026, under Regulation 31A(10) of the SEBI Listing Regulations related to reclassification from the "promoter and promoter group" category to the "public" category.
- Consequent to the consummation of the transaction under the Share Purchase Agreement dated May 23, 2026, and completion of the open offer in accordance with the SEBI Takeover Regulations, Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited acquired control of Bliss GVS Pharma Limited on September 28, 2026, and are classified as Promoters.
- The Board of Directors of the Company, at its meeting held on September 28, 2026, took note of the reclassification of the erstwhile Promoters and Promoter Group to the "Public" category under Regulation 31A(10).
Updated Promoter List
The following entities are now classified as Promoters and Promoter Group:
- Promoter: Anupam Rasayan India Limited, Mates Visa Consultancy Private Limited
- Promoter Group: Kiran Pallavi Investments LLC, Jainam Intermediates Private Limited, ARIL Transmodal Logistic Private Limited, ARIL Fluorospeciality Private Limited, Anupam Japan GK, Anupam Europe AG, Anupam USA, LLC, Anupam General Trading FZE, Doriath S.A.R.L., Kansas HoldCo Inc., Kansas HoldCo 1, Inc., Jayhawk Fine Chemicals Corporation, Tanfac Industries Limited
Financial Impact
Financial impact not quantified in the disclosure.
Parties Involved
- Acquiring Entities: Anupam Rasayan India Limited, Mates Visa Consultancy Private Limited